Anonymous
Guest
Anonymous
Guest
We will sell more in Alzheimer's in 2021 than we will in Oncology.
Oncology may be the future of Merck, but is Merck the place to be for Oncology?
Merck may not have a bright future. (A lot of things need to to go right).
What needs to occur is now into the rollout state, massive reductions in all departments all transfer of all sales to contract.
What needs to occur is now into the rollout state, massive reductions in all departments all transfer of all sales to contract.
That's why oncology is expanding, right.
A company with a market cap of $145 billion which grew 26% last year is disappearing. Of course, some of that growth is on the back of reductions in expenses but 26% is solid growth and a multi-billion dollar product in oncology is a sweet addition to the top line.
All the gloom and doom is for the completely uninformed and unskilled.
Your likely to experience doom and gloom soon. Mass layoffs on horizon and big increases in insurance costs. Oncology will not survive due to it's very poor management and I'll trained sales personnel.
Merck just sold a promising oncology drug to Pfizer for two billion! Sounds like a shafting to our group.
Before you open with enane comments, you should actually read the press release. It is US Merck! No wonder the oncology group is sooooo ineptIt's the German Merck you doomkoff.